Keyword      Search in       

Contact
Imprint
Site Map


Steps from Drug Development
to Marketing Authorisation
 

 

08.30 – 08.45 h Welcome
08.45 – 09.45 h Phases in API and Drug Development
09.45 – 10.45 h Clinial Trial Application and IMPD
10.45 – 11.15 h Coffee Break
11.15 – 12.15 h Marketing Authorisation Application and CTD
12.15 – 13.15 h Lunch Break
13.15 – 14.15 h Procedures for Marketing Authorisation Applications in the EU
14.15 – 14.45 h Coffee Break
14.45 – 15.45 h Quality Data in IMPD and CTD – What has to be provided?
15.45 – 16.45 h How to deal with Changes/Variations
16.45 – 17.00 h Final Discussion
ca. 17.00 h End of Training Course